- Email: [email protected]
Music as Medicine: Music-Thanatology and the Compounding of Art and Science into Palliative Music Prescriptions (TH335)
Vol. 45 No. 2 February 2013
Schedule With Abstracts
and resources, for palliative care clinicians in their approach to patients with uncommon illnesses.
Music as Medicine: Music-Thanatology and the Compounding of Art and Science into Palliative Music Prescriptions (TH335) Sharilyn Cohn, CMTh, SacredFlight, Portland, OR. James Excell, CMTh, Resonance Music, Ashland, OR. Tanya Stewart, MD FAAHPM, Evercare Oregon, Lake Oswego, OR. (All authors listed above had no relevant financial relationships to disclose.) Objectives 1. Describe methodologies used by music-thanatologists in the prescriptive delivery of music in the palliative care setting. 2. Be familiar with current music-thanatology research and its application to the practice of hospice and palliative care. 3. Gain tools to overcome barriers to incorporating music-thanatology into hospice or palliative care settings. Physical, emotional, and existential distress can adversely impact the quality of life of people who are terminally ill or dying and their loved ones. Music-thanatology is a palliative care modality uniting music, medicine, and spirituality to address these complex issues. The musicthanatologist brings harp and voice to the bedside, meeting fear, discomfort, and suffering with the prescriptive qualities of live music. Common patient responses include eased respirations, reduced anxiety and fear, deeper rest, and a sense of peace. Music-thanatology has become best practice in many hospitals and hospices, and is included in physicians’ standing orders for when a patient is placed on comfort measures or is being removed from life-sustaining treatment. Unfortunately, many patients do not receive the benefit of this service, in part due to institutional or palliative care providers’ lack of familiarity with music-thanatology. This session will address music-thanatology’s role in an interdisciplinary end-of-life care plan and provide the listener with an evidence based approach to this discipline. The learner will be guided through the discussion using a case vignette informed by the science of this field. Music-thanatologists will demonstrate a harp vigil during the session. Finally, the listener will leave with tools to teach hospital or hospice
355
administrators about the benefits of this service for patients and families.
Addressing End-of-Life Roadblocks for the Pulmonary Hypertension Patient (TH336) Lindy Landzaat, DO, University of Kansas, Leawood, KS. Timothy Williamson, MD, University of Kansas Medical Center, Kansas City, KS. Ryan Westhoff, MD, University of Kansas Medical Center, Kansas City, KS. (All authors listed above had no relevant financial relationships to disclose with the following exception: Williamson is on the speakers’ bureau and received an honorarium from Actelion Pharmaceuticals; he’s also on the speakers’ bureau and advisory board and received an honorarium from United Therapeutics.) Objectives 1. Review the classification, pathophysiology, and treatment of pulmonary hypertension. 2. List common barriers that pulmonary hypertension patients face near end of life. 3. Discuss some potential ways to overcome endof-life barriers for pulmonary hypertension patients. Pulmonary hypertension is a chronic life-limiting condition that remains without cure and goals of therapy universally include palliation of symptoms and often the hope of prolonging life. Pulmonary hypertension is a condition not well understood by many, but familiarity is important for hospice and palliative care providers. By understanding some of the pathophysiology, classification categories, and treatments for pulmonary hypertension, a hospice and palliative medicine clinician will be better poised to meet the end-of-life needs of their patient. Some of the most intensive therapies of advanced pulmonary hypertension, such as prostacylin analogs, carry their own unique challenges, not only for patients, but also for families and care teams. These challenges often unveil themselves most clearly at end of life. As pulmonary hypertension specialists and centers continue to expand, palliative care and hospice clinicians will have increased exposure to these shared end-of-life challenges. The hospice and palliative care clinician who can anticipate and address these barriers will not only be better prepared and empowered, but more effective end-of-life care delivery. This concurrent session aims to provide a foundation for improved understanding of pulmonary hypertension as
Schedule With Abstracts
and resources, for palliative care clinicians in their approach to patients with uncommon illnesses.
Music as Medicine: Music-Thanatology and the Compounding of Art and Science into Palliative Music Prescriptions (TH335) Sharilyn Cohn, CMTh, SacredFlight, Portland, OR. James Excell, CMTh, Resonance Music, Ashland, OR. Tanya Stewart, MD FAAHPM, Evercare Oregon, Lake Oswego, OR. (All authors listed above had no relevant financial relationships to disclose.) Objectives 1. Describe methodologies used by music-thanatologists in the prescriptive delivery of music in the palliative care setting. 2. Be familiar with current music-thanatology research and its application to the practice of hospice and palliative care. 3. Gain tools to overcome barriers to incorporating music-thanatology into hospice or palliative care settings. Physical, emotional, and existential distress can adversely impact the quality of life of people who are terminally ill or dying and their loved ones. Music-thanatology is a palliative care modality uniting music, medicine, and spirituality to address these complex issues. The musicthanatologist brings harp and voice to the bedside, meeting fear, discomfort, and suffering with the prescriptive qualities of live music. Common patient responses include eased respirations, reduced anxiety and fear, deeper rest, and a sense of peace. Music-thanatology has become best practice in many hospitals and hospices, and is included in physicians’ standing orders for when a patient is placed on comfort measures or is being removed from life-sustaining treatment. Unfortunately, many patients do not receive the benefit of this service, in part due to institutional or palliative care providers’ lack of familiarity with music-thanatology. This session will address music-thanatology’s role in an interdisciplinary end-of-life care plan and provide the listener with an evidence based approach to this discipline. The learner will be guided through the discussion using a case vignette informed by the science of this field. Music-thanatologists will demonstrate a harp vigil during the session. Finally, the listener will leave with tools to teach hospital or hospice
355
administrators about the benefits of this service for patients and families.
Addressing End-of-Life Roadblocks for the Pulmonary Hypertension Patient (TH336) Lindy Landzaat, DO, University of Kansas, Leawood, KS. Timothy Williamson, MD, University of Kansas Medical Center, Kansas City, KS. Ryan Westhoff, MD, University of Kansas Medical Center, Kansas City, KS. (All authors listed above had no relevant financial relationships to disclose with the following exception: Williamson is on the speakers’ bureau and received an honorarium from Actelion Pharmaceuticals; he’s also on the speakers’ bureau and advisory board and received an honorarium from United Therapeutics.) Objectives 1. Review the classification, pathophysiology, and treatment of pulmonary hypertension. 2. List common barriers that pulmonary hypertension patients face near end of life. 3. Discuss some potential ways to overcome endof-life barriers for pulmonary hypertension patients. Pulmonary hypertension is a chronic life-limiting condition that remains without cure and goals of therapy universally include palliation of symptoms and often the hope of prolonging life. Pulmonary hypertension is a condition not well understood by many, but familiarity is important for hospice and palliative care providers. By understanding some of the pathophysiology, classification categories, and treatments for pulmonary hypertension, a hospice and palliative medicine clinician will be better poised to meet the end-of-life needs of their patient. Some of the most intensive therapies of advanced pulmonary hypertension, such as prostacylin analogs, carry their own unique challenges, not only for patients, but also for families and care teams. These challenges often unveil themselves most clearly at end of life. As pulmonary hypertension specialists and centers continue to expand, palliative care and hospice clinicians will have increased exposure to these shared end-of-life challenges. The hospice and palliative care clinician who can anticipate and address these barriers will not only be better prepared and empowered, but more effective end-of-life care delivery. This concurrent session aims to provide a foundation for improved understanding of pulmonary hypertension as